The Scientific Team at BiomX spearheads the research and development of phage cocktails to target harmful bacteria in skin conditions and chronic diseases. Comprised of scientific founders, a CMC project leader, and an SVP of clinical development, the team designs, tests, and optimizes these therapies to ensure efficacy and safety for clinical applications.